ORTEXORTEX News
Tracking XPEL? Get live short interest, options flow, and signals on ORTEX.Sign up free →
XP
Trader NoteXPEL

XPEL Heads Into Earnings With Shorts Elevated and Options Skewed

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 3 min readdata as of 4 Nov 2026, 19:20

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

XPEL reports after the bell on November 5 with shorts still meaningfully positioned, options traders heavily skewed toward puts, and the stock down 5.3% in a single session on November 3.

Short interest at 9.4% of the free float is not extreme, but it is real and has been drifting lower over the past week. Bears trimmed about 3.7% of their position over the past five days, bringing shares short to roughly 2.61 million. That steady covering since late October, from a peak near 2.96 million shares on October 23, suggests some pre-earnings risk reduction rather than a conviction-driven exit. Cost to borrow is negligible at 0.45%, and availability is comfortable at 173%, meaning the lending market is not squeezed and new shorts face no particular friction. The ORTEX short score, however, tells a different story: at 75, it ranks in just the 5th percentile of the universe for bearish positioning signals, placing XPEL firmly in watched territory heading into the print.

The options market is the most striking data point this week. The put/call ratio of 10.52 is not quite at its 52-week high of 12.78, but it is running well above the 20-day average of 7.3. That ratio flipped sharply higher in the week of October 19, jumping from levels below 1 to double digits, and has stayed elevated since. At roughly 0.6 standard deviations above the 20-day mean the z-score is not screaming, but the absolute level of the PCR is unusual: for every call contract outstanding, more than ten puts are open. For a stock the size of XPEL, that is a heavily skewed protection trade, not a gradual tilt.

The Street view is constructive but dated. The most recent analyst changes on record are from early August 2026, when Freedom Broker upgraded to Buy with a $60 target and B. Riley raised its target to $65 while maintaining Buy. The consensus sits at three Buys against zero Holds, with a mean price target near $61.67, implying roughly 45% upside from the current $42.49. The valuation has compressed alongside the share price: the PE multiple has fallen about 1.2 points over the past 30 days to 16.2x, and EV/EBITDA has eased to 9.6x. Neither is stretched. The factor score picture is mixed: EPS momentum ranks in the 63rd percentile, but the short-score rank sits at the 5th, and days-to-cover ranks at the 1st, flagging the market's caution even as earnings revisions point modestly higher.

Ownership is concentrated in a small number of hands. BlackRock holds 13.9% and Wasatch Advisors 12.4%, both reporting as of September 30. Alta Fox Capital Management filed a Schedule 13G/A in May disclosing a 7% stake, up from 5.2% previously. That is a passive filing rather than an activist 13D, but the stake is large and the increase was material. As always with 13D/G disclosures, positions are as last filed and holders dropping below 5% are not required to file again. Insider activity in the past 90 days amounts to net zero shares, with recent transactions all coded as option exercises and award grants rather than open-market purchases or sales.

Wikipedia attention for XPEL spiked sharply in mid-October, with a z-score of 5.9 against its own 90-day history, though this measures retail curiosity rather than any revenue-related signal. The one useable comparable earnings reaction in the history is the August 2026 print, when the stock fell 2.8% the day after results before recovering 1.5% over the following five sessions. The November 5 print will show how the company is navigating what has been a difficult month for the stock, down 5.5% on the month, with the key question being whether the recent short covering was prescient or premature.

Stocks in this article

See the live data behind this article on ORTEX.

Open XPEL on ORTEX →

How this article was generated

Generated
4 Nov 2026, 19:28
Data as of
4 Nov 2026, 19:20
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.